Fig. 1 · Structure

Documents & Downloads

Retapamulin (SB-275833)

Cat. No. A11139 CAS 224452-66-8

protein synthesis inhibitor

Retapamulin is an antibacterial agent, specifically a protein synthesis inhibitor

In Stock

Publications for Retapamulin

1 publication citing this product

  1. Merianne Mohamad, .et al. , Nucleic Acids Res, 2022, Feb 28;50(4):2128-2142 PMID: 35137182

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

In a crystal structure of the isolated Deinococcus radiodurans large ribosomal subunit, retapamulin (SB-275833) occupied the peptidyl transferase center, with its tricyclic core oriented toward the A-site and its C14 extension toward the P-site. The retapamulin complex was resolved at 3.66 Å. Comparison with the native subunit supported an induced-fit rearrangement of the binding pocket. These structural observations do not establish cellular selectivity, mammalian safety or efficacy. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Retapamulin (SB-275833) Research Summary

This section summarizes 1 in vitro study of Retapamulin (SB-275833) from 1 published reference.

Retapamulin (SB-275833) In Vitro Studies

Retapamulin binding site in an isolated bacterial large ribosomal subunit

Biochemical assay · Isolated Deinococcus radiodurans large ribosomal subunit (D50S), X-ray crystal structure [1]

The retapamulin complex places the compound at the peptidyl transferase center. Its tricyclic core and C14 extension occupy different parts of this site. Comparison with the native subunit supports rearrangement of the binding pocket around the bound compound. This is structural evidence rather than a cellular inhibition or efficacy measurement.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Resolution of the retapamulin–D50S crystal structureX-ray resolution (Å) 3.66 Å[1]

Literature-Reported Treatment Conditions

Method
Structural analysis of the retapamulin–D50S complex; native D50S structure used as reference.
Reported limits
Crystallographic preparation conditions are not presented as a cellular exposure regimen. Vehicle and supplier/lot authentication were not established from the inspected method; no cell or animal dose is inferred.
Methods and source locations

Compound reported in the paper: Retapamulin; Compound label in the paper: SB-275833

Literature evidence for named retapamulin at an isolated bacterial ribosomal target. No catalog-lot validation, salt equivalence, cellular selectivity, susceptibility or animal/clinical efficacy inference.

Published PDF pp. 4292–4293, Results, Table 1 retapamulin column, Fig. 2 b/e/h; p. 4296, Materials and Methods.

Resolution of the retapamulin–D50S crystal structure: X-ray crystallography; Table 1 retapamulin (SB-275833) column. — Published PDF p. 4293, Table 1: Retapamulin (SB-275833), Resolution row; corroborated by p. 4292 Results and Fig. 2 caption.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 224452-66-8
Applications protein synthesis inhibitor
Formula C30H47NO4S
Molecular Weight 517.3
Synonyms SB-275833
SMILES
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 102 mg/mL (197 mM)
Water Insoluble
Ethanol 102 mg/mL (197 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Retapamulin (SB-275833) Research References

  1. [1] Chen Davidovich, Anat Bashan, Tamar Auerbach-Nevo, et al. Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity Proceedings of the National Academy of Sciences of the United States of America (2007). PMID: 17360517 DOI: 10.1073/pnas.0700041104 Source material

Publications

1 publication citing this product

  1. Merianne Mohamad, .et al. , Nucleic Acids Res, 2022, Feb 28;50(4):2128-2142 PMID: 35137182

Added to your cart

View Cart Checkout
Loading...